LFG
CRDF icon

Larson Financial Group’s Cardiff Oncology CRDF Stock Holding History

Larson Financial Group’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-328
Closed -$1.03K – 3485
2025
Q2 		$1.03K Buy
+328
New +$1K ﹤0.01% 2643
2023
Q2 		– Sell
-150
Closed -$248 – 1580
2023
Q1 		$248 Hold
150
– – ﹤0.01% 1458
2022
Q4 		$210 Hold
150
– – ﹤0.01% 1422
2022
Q3 		$0 Hold
150
– – ﹤0.01% 1310
2022
Q2 		$0 Hold
150
– – ﹤0.01% 1202
2022
Q1 		$0 Hold
150
– – ﹤0.01% 1062
2021
Q4 		$1K Buy
+150
New +$894 ﹤0.01% 1000

Other funds holding CRDF

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $6.71B AUM 23.99% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Larson Financial Group's CRDF Position: Q3 2025 in Review

Larson Financial Group sold out of Cardiff Oncology (CRDF) in Q3 2025, closing a stake of 328 shares — an estimated $1.03K sold.

Larson Financial Group first reported a position in CRDF in Q4 2021 and held it in 7 quarters. The position peaked at $1.03K in Q2 2025. 112 funds tracked by Wall St. Rank hold CRDF as of Q3 2025.

  • Larson Financial Group reported no remaining Cardiff Oncology position as of Q3 2025 after selling out during the quarter.
  • Larson Financial Group sold 328 Cardiff Oncology shares in Q3 2025, an estimated $1.03K.
  • Larson Financial Group first reported a position in Cardiff Oncology in Q4 2021 and held it in 7 quarters.
  • Larson Financial Group's Cardiff Oncology position peaked at $1.03K in Q2 2025.
  • 112 funds tracked by Wall St. Rank held Cardiff Oncology as of Q3 2025.

Based on Larson Financial Group's 13F filing for Q3 2025, filed 14 Nov 2025.